What up? DXB- no other way.., page-24

yeah i also queried as to why only a small number of patients were reported on, however after further research, the only 2 main endpoints as defined by the study are 1. safety & 2. proteinuria reduction of 50% or more above standard of care.

so 3/11 saw reductions of 50% or more...if there were others with reduction of say 30% (still a great result), then this was not reported as it did not fall within the endpoints defined by the study.

I reckon once results are released, we will know the number of both those 50% or more in addition to a general, overall average of all participants in the trial.

if only they didn't raise $$$ at such ridiculous levels.